Today, we’re witnessing a highly disturbing trend in healthcare: decisions about patient care being influenced not by medical expertise but by administrative policy.
In some cases, reimbursement structures and bureaucratic determinations—not science and not clinical judgment—effectively limit the treatment options available to patients.
Let’s be clear: when multiple treatments are scientifically validated, peer-reviewed, clinically appropriate, and have comparable — or even superior — outcomes, no external agency or third-party payer should be allowed to choose a “winner” and sabotage everything else.
That’s why this short episode of the Distinctive Dermatologist is so critical. Please listen and share.